Progesterone receptor agonists and antagonists

被引：6
|
作者：
Allan, G [1 ]
Macielag, M [1 ]
机构：
[1] RW Johnson Pharmaceut Res Inst, Raritan, NJ 08869 USA
来源：
EXPERT OPINION ON THERAPEUTIC PATENTS | 1999年 / 9卷 / 07期
关键词：
contraception; endometriosis; leiomyomata; mifepristone; progestin;
D O I：
10.1517/13543776.9.7.955
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Steroidal progestin agonists have long been used in oral contraceptives, and the progestin antagonist mifepristone is used as an abortifacient. Progestin antagonists are also likely to be useful for treating breast cancer and various gynaecological disorders. This patent review relates to progestin receptor agonists and antagonists, focusing on applications filed over the past three years. Two emerging themes will be elaborated upon: the development of novel steroidal and non-steroidal compounds, and the elucidation of new therapeutic uses for progestin antagonists.
引用
收藏
页码：955 / 962
页数：8
相关论文
共 50 条
  • [21] Synthesis and SAR of amino acid-derived heterocyclic progesterone receptor full and partial agonists
    Hammond, Marlys
    Patterson, Jaclyn R.
    Manns, Sharada
    Hoang, Tram H.
    Washburn, David G.
    Trizna, Walter
    Glace, Lindsay
    Grygielko, Eugene T.
    Nagilla, Rakesh
    Nord, Melanie
    Fries, Harvey E.
    Minick, Douglas J.
    Laping, Nicholas J.
    Bray, Jeffrey D.
    Thompson, Scott K.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (10) : 2637 - 2641
  • [22] Gene expression effects of glucocorticoid and mineralocorticoid receptor agonists and antagonists on normal human skeletal musclele
    Chadwick, Jessica A.
    Hauck, J. Spencer
    Gomez-Sanchez, Celso E.
    Gomez-Sanchez, Elise P.
    Rafael-Fortney, Jill A.
    PHYSIOLOGICAL GENOMICS, 2017, 49 (06) : 277 - 286
  • [23] Perturbations in Progesterone Receptor Isoforms in Endometriosis
    Karim, Abdul Kadir Abdul
    Shafiee, Mohamad Nasir
    Abd Aziz, Nor Haslinda
    Omar, Mohd Hashim
    Zin, Reena Rahayu Md
    Mokhtar, Norfilza M.
    JOURNAL OF REPRODUCTIVE MEDICINE, 2019, 64 (7-8) : 275 - 281
  • [24] Interest of selective progesterone receptor modulators in endometriosis
    Merviel, P.
    Lourdel, E.
    Sanguin, S.
    Gagneur, O.
    Cabry, R.
    Nasreddine, A.
    GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2013, 41 (09): : 524 - 528
  • [25] Selective progesterone receptor modulators and reproductive health
    Nieman, Lynnette K.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2022, 29 (04) : 406 - 412
  • [26] Non-steroidal progesterone receptor modulators
    Zhang, PW
    Fensome, A
    Wrobel, J
    Winneker, R
    Zhang, ZM
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (12) : 1839 - 1847
  • [27] 6-Arylcoumarins as Novel Nonsteroidal Type Progesterone Antagonists: An Example with Receptor-Binding-Dependent Fluorescence
    Sakai, Haruka
    Hirano, Tornoya
    Mori, Shuichi
    Fujii, Shinya
    Masuno, Hiroyuki
    Kinoshita, Marie
    Kagechika, Hiroyuki
    Tanatani, Aya
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (20) : 7055 - 7065
  • [28] Progesterone receptor B over progesterone receptor A prevents recurrence in bilateral endometriomas
    Aslan, Ozgur
    Yildiz, Sukru
    Kaya, Cihan
    Altinay, Serdar
    Aydiner, Ilke Esin
    Karabulut, Esra
    Ekin, Murat
    Yasar, Levent
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2024, 70 (09):
  • [29] Glucocorticoid receptor antagonists
    Clark, Robin D.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2008, 8 (09) : 813 - 838
  • [30] Small molecule agonists and antagonists for the LH and FSH receptors
    Guo, T
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (11) : 1555 - 1564
12345